$DVAX
DYNAVAX TECHNOLOGIES CORP

2021 Q2 Form 10-Q Financial Statement

#000156459021040926 Filed on August 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $52.77M $2.668M $10.92M
YoY Change 1877.77% -67.86% 89.16%
Cost Of Revenue $14.85M $1.170M $4.650M
YoY Change 1168.8% -73.65% 14.25%
Gross Profit $37.92M $1.500M $6.270M
YoY Change 2428.13% -61.14% 268.82%
Gross Profit Margin 71.87% 56.22% 57.42%
Selling, General & Admin $21.58M $18.95M $20.93M
YoY Change 13.87% 6.12% 14.05%
% of Gross Profit 56.91% 1263.6% 333.75%
Research & Development $7.167M $5.884M $4.653M
YoY Change 21.8% -63.67% -78.06%
% of Gross Profit 18.9% 392.27% 74.21%
Depreciation & Amortization $1.092M $1.250M $3.310M
YoY Change -12.64% -67.11% -16.62%
% of Gross Profit 2.88% 83.33% 52.79%
Operating Expenses $28.75M $24.84M $25.58M
YoY Change 15.75% -47.46% 39.41%
Operating Profit $9.172M -$23.34M -$19.31M
YoY Change -139.3% -40.11% -48.98%
Interest Expense $3.109M $4.732M $4.731M
YoY Change -34.3% 2.91% 73.04%
% of Operating Profit 33.9%
Other Income/Expense, Net -$173.0K -$111.0K $322.0K
YoY Change 55.86% -9.76% 77.9%
Pretax Income $4.473M -$51.58M -$12.60M
YoY Change -108.67% 20.77% -68.24%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $4.473M -$51.58M -$12.60M
YoY Change -108.67% 20.76% -68.25%
Net Earnings / Revenue 8.48% -1933.25% -115.34%
Basic Earnings Per Share $0.04 -$0.53 -$0.15
Diluted Earnings Per Share $0.02 -$0.53 -$0.25
COMMON SHARES
Basic Shares Outstanding 114.6M 97.34M 85.48M
Diluted Shares Outstanding 118.8M 97.34M 85.65M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $345.8M $200.7M $129.5M
YoY Change 72.3% 42.85% -29.31%
Cash & Equivalents $129.6M $60.49M $37.90M
Short-Term Investments $216.2M $140.2M $91.60M
Other Short-Term Assets $45.75M $9.500M $8.400M
YoY Change 381.59% 41.79% 42.37%
Inventory $86.45M $54.39M $48.10M
Prepaid Expenses
Receivables $105.9M $900.0K $8.100M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $583.9M $265.5M $194.1M
YoY Change 119.93% 38.68% -12.76%
LONG-TERM ASSETS
Property, Plant & Equipment $57.71M $58.30M $59.30M
YoY Change -1.01% 69.51% 0.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.067M $3.400M $3.500M
YoY Change 19.62% 88.99% -5.41%
Total Long-Term Assets $64.00M $63.80M $65.20M
YoY Change 0.32% -15.64% -12.01%
TOTAL ASSETS
Total Short-Term Assets $583.9M $265.5M $194.1M
Total Long-Term Assets $64.00M $63.80M $65.20M
Total Assets $647.9M $329.3M $259.3M
YoY Change 96.75% 23.3% -12.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.08M $2.700M $4.600M
YoY Change 347.37% -75.95% -61.34%
Accrued Expenses $33.37M $18.60M $18.50M
YoY Change 79.39% -4.86% -22.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $204.6M $53.20M $29.28M
YoY Change 284.67% 19.35% -30.7%
LONG-TERM LIABILITIES
Long-Term Debt $220.0M $179.7M $179.6M
YoY Change 22.4% 1.73% 2.23%
Other Long-Term Liabilities $139.9M $1.910M $38.60M
YoY Change 7226.07% 197.05% 8652.83%
Total Long-Term Liabilities $359.9M $1.910M $179.6M
YoY Change 18742.25% -98.92% 1.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $204.6M $53.20M $29.28M
Total Long-Term Liabilities $359.9M $1.910M $179.6M
Total Liabilities $564.5M $271.0M $208.9M
YoY Change 108.3% 5.66% -17.59%
SHAREHOLDERS EQUITY
Retained Earnings -$1.283B
YoY Change 11.7%
Common Stock $1.343B
YoY Change 15.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $83.38M $58.30M $11.82M
YoY Change
Total Liabilities & Shareholders Equity $647.9M $329.3M $259.3M
YoY Change 96.75% 23.3% -12.58%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $4.473M -$51.58M -$12.60M
YoY Change -108.67% 20.76% -68.25%
Depreciation, Depletion And Amortization $1.092M $1.250M $3.310M
YoY Change -12.64% -67.11% -16.62%
Cash From Operating Activities $110.8M -$21.82M -$26.87M
YoY Change -607.75% -39.99% -32.67%
INVESTING ACTIVITIES
Capital Expenditures -$1.062M -$690.0K $2.352M
YoY Change 53.91% -90.8% -39.41%
Acquisitions
YoY Change
Other Investing Activities -$62.68M -$48.70M $19.92M
YoY Change 28.71% 41.04% -21.88%
Cash From Investing Activities -$63.76M -$49.38M $10.56M
YoY Change 29.11% 17.52% -27.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $14.23M
YoY Change 4.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.338M 93.48M 14.54M
YoY Change -96.43% 26608.57% -83.53%
NET CHANGE
Cash From Operating Activities 110.8M -21.82M -26.87M
Cash From Investing Activities -63.76M -49.38M 10.56M
Cash From Financing Activities 3.338M 93.48M 14.54M
Net Change In Cash 50.37M 22.28M -1.989M
YoY Change 126.09% -128.55% -103.17%
FREE CASH FLOW
Cash From Operating Activities $110.8M -$21.82M -$26.87M
Capital Expenditures -$1.062M -$690.0K $2.352M
Free Cash Flow $111.9M -$21.13M -$29.22M
YoY Change -629.35% -26.78% -33.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M9D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y3M14D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10D
dei Entity File Number
EntityFileNumber
001-34207
dei Entity Registrant Name
EntityRegistrantName
Dynavax Technologies Corp
CY2021Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
219959000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
23455000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44006000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39880000
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
1927000
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13587000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14925000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10537000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17045000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
384000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
211000
us-gaap Net Income Loss
NetIncomeLoss
5364000
us-gaap Net Income Loss
NetIncomeLoss
-64174000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.70
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118830000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97339000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114978000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91408000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4473000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-51579000
us-gaap Net Income Loss
NetIncomeLoss
5364000
us-gaap Net Income Loss
NetIncomeLoss
-64174000
CY2021Q2 dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
38000
CY2020Q2 dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
-99000
dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
29000
dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
192000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
375000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
579000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1015000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
100000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
413000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
480000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-986000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4886000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51099000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4378000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63882000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
99762000
CY2021Q2 dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
948000
CY2021Q2 dvax Adjustments To Additional Paid In Capital Purchase Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCalls
-27240000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
83380000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
58693000
dvax Stock Issued Exercise Of Warrants During Period Value New Issues
StockIssuedExerciseOfWarrantsDuringPeriodValueNewIssues
7928000
dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
1335000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
383000
dvax Adjustments To Additional Paid In Capital Purchase Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCalls
-27240000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9747000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-986000
us-gaap Net Income Loss
NetIncomeLoss
5364000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
83380000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11824000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2020Q2 dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
14000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
93467000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4088000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
480000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-51579000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58295000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8290000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
13000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
311000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
107696000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5866000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
292000
us-gaap Net Income Loss
NetIncomeLoss
-64174000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58295000
us-gaap Net Income Loss
NetIncomeLoss
5364000
us-gaap Net Income Loss
NetIncomeLoss
-64174000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2202000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2063000
dvax Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1326000
dvax Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1261000
dvax Gain On Disposal Of Property And Equipment And Lease Termination
GainOnDisposalOfPropertyAndEquipmentAndLeaseTermination
76000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-369000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
78000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
23455000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17045000
us-gaap Share Based Compensation
ShareBasedCompensation
9747000
us-gaap Share Based Compensation
ShareBasedCompensation
5866000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
2500000
dvax Non Cash Interest Expense
NonCashInterestExpense
2806000
dvax Non Cash Interest Expense
NonCashInterestExpense
1726000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-908000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
83239000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-7983000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22762000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13060000
dvax Increase Decrease In Prepaid Manufacturing
IncreaseDecreaseInPrepaidManufacturing
6875000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
247000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2083000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
265000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-163000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7209000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3993000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
1554000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
1383000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
91345000
dvax Increase Decrease In Long Term Deferred Revenue
IncreaseDecreaseInLongTermDeferredRevenue
106950000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
7757000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3355000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
148820000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48687000
dvax Payments To Acquire Technology Licenses
PaymentsToAcquireTechnologyLicenses
7000000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
164928000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
103182000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
81355000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
74400000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2812000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3038000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86385000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38820000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28156000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
107697000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
97527000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
219822000
dvax Payments For Purchase Of Capped Call Options
PaymentsForPurchaseOfCappedCallOptions
27240000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
190194000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3376000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
1335000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
13000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
383000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
311000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35638000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
108021000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-546000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20602000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32310000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40100000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129837000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60702000
us-gaap Interest Paid Net
InterestPaidNet
2053000
us-gaap Interest Paid Net
InterestPaidNet
7757000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2131000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
124000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
345800000
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
225500000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4500000
us-gaap Net Income Loss
NetIncomeLoss
5400000
CY2021Q2 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that may affect the amounts reported in the condensed consolidated financial statements and accompanying notes, including amounts of revenues and expenses during the reported periods. Management’s estimates are based on historical information available as of the date of the condensed consolidated financial statements and various other assumptions we believe are reasonable under the circumstances. On an ongoing basis, we evaluate our estimates, judgments and methodologies. Significant estimates and assumptions in the condensed consolidated financial statements include those related to revenue recognition; accounts receivable; useful lives of long-lived assets, impairment of long-lived assets, including goodwill; valuation procedures for right-of-use assets and operating lease liabilities; valuation of inventory; balance sheet classification of convertible notes; fair value of warrants; balance sheet classification of Convertible Notes; income taxes, including the valuation allowance for deferred tax assets; research and development expenses; contingencies and share-based compensation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ materially from these estimates under different assumptions or conditions and could be further impacted by the COVID-19 pandemic. Changes in estimates are reflected in reported results in the period in which they become known.</p>
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021Q2 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129608000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32073000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60485000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39884000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
229000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
237000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
217000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
216000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129837000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32310000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60702000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40100000
CY2021Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
345744000
CY2021Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
60000
CY2021Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
345804000
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
165005000
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
48000
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
165036000
CY2021Q2 dvax Lessor Sublease Rentals Payments To Be Received Due
LessorSubleaseRentalsPaymentsToBeReceivedDue
58785000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
57044000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
214386000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
214446000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1750000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1750000
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
216136000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
216196000
CY2021Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28041000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
25121000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19852000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30293000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
38558000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8275000
CY2021Q2 us-gaap Inventory Net
InventoryNet
86451000
CY2020Q4 us-gaap Inventory Net
InventoryNet
63689000
CY2021Q2 dvax Prepaid Manufacturing
PrepaidManufacturing
36300000
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1570000
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1561000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3130000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3153000
us-gaap Operating Lease Payments
OperatingLeasePayments
3400000
us-gaap Operating Lease Payments
OperatingLeasePayments
3400000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3489000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3247000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32897000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34789000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
36386000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
38036000
CY2021Q2 dvax Lessor Sublease Rentals Payments To Be Received Remainder Of Fiscal Year
LessorSubleaseRentalsPaymentsToBeReceivedRemainderOfFiscalYear
2630000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3486000
CY2021Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Two
LessorSubleaseRentalsPaymentsToBeReceivedDueYearTwo
5357000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6248000
CY2021Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Three
LessorSubleaseRentalsPaymentsToBeReceivedDueYearThree
5518000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5384000
CY2021Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Four
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFour
5684000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5528000
CY2021Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Year Five
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFive
5854000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5677000
CY2021Q2 dvax Lessor Sublease Rentals Payments To Be Received Due Thereafter
LessorSubleaseRentalsPaymentsToBeReceivedDueThereafter
33742000
CY2021Q2 dvax Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
30721000
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
20658000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
36386000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y9M18D
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
106800000
CY2004Q4 us-gaap Pledged Assets Separately Reported Securities Pledged Under Letter Of Credit Facilities At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue
200000
CY2021Q2 us-gaap Security Owned And Pledged As Collateral Fair Value
SecurityOwnedAndPledgedAsCollateralFairValue
200000
CY2020Q3 dvax Payment To Holdings
PaymentToHoldings
2500000
CY2021Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
736000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
736000
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
137000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
137000
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
873000
us-gaap Interest Expense Debt
InterestExpenseDebt
873000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52767000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2668000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136102000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13587000
CY2021Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-333000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-410000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-64174000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2097000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2043000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-51579000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4954000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-64174000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114629000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97339000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113339000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91408000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1630000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1639000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2571000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118830000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97339000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114978000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91408000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22494000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21257000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20803000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21257000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114756092
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18525000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8505000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2817000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.31
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
308000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.69
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10247000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.03
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17136000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9876000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
11.12
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
16644000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5966000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.04
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9627000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5024000
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
4088000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
9747000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5866000

Files In Submission

Name View Source Status
0001564590-21-040926-index-headers.html Edgar Link pending
0001564590-21-040926-index.html Edgar Link pending
0001564590-21-040926.txt Edgar Link pending
0001564590-21-040926-xbrl.zip Edgar Link pending
dvax-10q_20210630.htm Edgar Link pending
dvax-10q_20210630_htm.xml Edgar Link completed
dvax-20210630.xsd Edgar Link pending
dvax-20210630_cal.xml Edgar Link unprocessable
dvax-20210630_def.xml Edgar Link unprocessable
dvax-20210630_lab.xml Edgar Link unprocessable
dvax-20210630_pre.xml Edgar Link unprocessable
dvax-ex101_313.htm Edgar Link pending
dvax-ex102_261.htm Edgar Link pending
dvax-ex103_263.htm Edgar Link pending
dvax-ex106_311.htm Edgar Link pending
dvax-ex107_312.htm Edgar Link pending
dvax-ex311_9.htm Edgar Link pending
dvax-ex312_7.htm Edgar Link pending
dvax-ex321_6.htm Edgar Link pending
dvax-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending